MedTrace Logo

Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus

NCT01087242 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2010-03-16

No results posted yet for this study

Summary

This is a randomized, doubled blind, dose-paralleled control, multi-centre clinical trail,to evaluate the efficacy of Tang-min-ling pills in the treatment of type 2 diabetes mellitus.

Conditions

Interventions

DRUG

Tang-min Lin pill

Tang-min Lin pill 6g,tid,treat 12 weeks.

Sponsors & Collaborators

  • Tianjin University of Traditional Chinese Medicine

    collaborator OTHER

  • Liaoning University of Traditional Chinese Medicine

    collaborator OTHER

  • Shanghai University of Traditional Chinese Medicine

    collaborator OTHER

  • Beijing Hospital

    collaborator OTHER_GOV

  • Tianjin Tasly Pharmaceutical Co., Ltd

    collaborator INDUSTRY

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Wu S Tao, pro. · Tian Jin university of tradtional chinese medicine

  • Lian F Mei, doctor · Guang'anmen Hospital of China Academy of Chinese Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-12-31
Completion
2010-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01087242 on ClinicalTrials.gov